Serum <scp>sTREM2</scp> Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis

These findings suggest that serum sTREM2 may have limited value as a biomarker of disability progression in PPMS.

Authors

Institutions

Publication Details

Journal
European Journal of Neurology
Published
2026-01-30
DOI
https://doi.org/10.1111/ene.70480
Primary Topic
Inflammation biomarkers and pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis

Klaus Jun. Berek, Igal Rosenstein, Harald Hegen, Roberto Álvarez‐Lafuente et al.
European Journal of Neurology
Inflammation biomarkers and pathways
article

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis

Klaus Jun. Berek, Igal Rosenstein, Harald Hegen, Roberto Álvarez‐Lafuente, Nicolás Fissolo, Jan Ludvig Lycke, Luisa María Villar, Franziska Bachhuber, Lucía Gutiérrez, J. Lünemann, ENRIC MONREAL, Pascal Benkert, R. Furlan, Antonio Sánchez‐López, Xavier Montalban, Michael Khalil, Hayrettin Tumani, Yolanda Blanco, Manuel Comabella, Andreu Vilaseca‐Jolonch, Jens Kuhle, Francisco Pérez‐Miralles, Tamara Castillo‐Triviño, Antonio García‐Merino, Sergio Martínez‐Yelamos, Nieves Téllez
article en

Abstract

These findings suggest that serum sTREM2 may have limited value as a biomarker of disability progression in PPMS.

European Journal of NeurologyVol. 33(2)
Medical University of Lublin (PL), Innsbruck Medical University (AT), University of Basel (CH), Universidad de Alcalá (ES), Universität Innsbruck (AT), Universität Ulm (DE), Medical University of Graz (AT), Bellvitge University Hospital (ES), University Hospital of Basel (CH), Hospital Universitari i Politècnic La Fe (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Institut d'Investigació Biomédica de Bellvitge (ES), Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES), Biogipuzkoa Health Research Institute (ES), Vall d'Hebron Institut de Recerca (ES), University Hospital Münster (DE), Hospital Universitario Puerta de Hierro Majadahonda (ES), Ajuntament de L’Hospitalet (ES), Instituto Ramón y Cajal de Investigación Sanitaria (ES), Department of Biomedicine Basel (CH), IRCCS Ospedale San Raffaele (IT), Hospital Clínico Universitario de Valladolid (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Hospital Universitario Ramón y Cajal (ES), University of Gothenburg (SE)
Generalitat de Catalunya, Agència de Gestió d'Ajuts Universitaris i de Recerca
Openalex Percentile: Top 72%
Inflammation biomarkers and pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.